Cargando…

Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide

The structures of two azide containing imidazole derivatives are reported. Allylic azides are fairly reactive making them attractive starting compounds to convert into amides. The first, C(8)H(12)N(6)O(2)S, contains one azide group with an N(α)—N(β) distance of 1.229 (2) Å and an N(β)—N(γ) distance...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Lorenzo M., Moore, Raakiyah Y., Gutierrez, Marcela Torres, Herath, Apsara K., Lovely, Carl J., Yousufuddin, Muhammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505610/
https://www.ncbi.nlm.nih.gov/pubmed/31110813
http://dx.doi.org/10.1107/S205698901900519X
_version_ 1783416790553985024
author Cruz, Lorenzo M.
Moore, Raakiyah Y.
Gutierrez, Marcela Torres
Herath, Apsara K.
Lovely, Carl J.
Yousufuddin, Muhammed
author_facet Cruz, Lorenzo M.
Moore, Raakiyah Y.
Gutierrez, Marcela Torres
Herath, Apsara K.
Lovely, Carl J.
Yousufuddin, Muhammed
author_sort Cruz, Lorenzo M.
collection PubMed
description The structures of two azide containing imidazole derivatives are reported. Allylic azides are fairly reactive making them attractive starting compounds to convert into amides. The first, C(8)H(12)N(6)O(2)S, contains one azide group with an N(α)—N(β) distance of 1.229 (2) Å and an N(β)—N(γ) distance of 1.128 (2) Å. The second, C(8)H(11)N(9)O(2)S, contains two azide groups with an average N(α)—N(β) distance of 1.249 (2) Å and an average N(β)—N(γ) distance of 1.132 (2) Å. Each compound contains a bulky protecting group (di­methyl­amino­sulfon­yl) which can be easily removed under mildly acidic conditions.
format Online
Article
Text
id pubmed-6505610
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-65056102019-05-20 Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide Cruz, Lorenzo M. Moore, Raakiyah Y. Gutierrez, Marcela Torres Herath, Apsara K. Lovely, Carl J. Yousufuddin, Muhammed Acta Crystallogr E Crystallogr Commun Research Communications The structures of two azide containing imidazole derivatives are reported. Allylic azides are fairly reactive making them attractive starting compounds to convert into amides. The first, C(8)H(12)N(6)O(2)S, contains one azide group with an N(α)—N(β) distance of 1.229 (2) Å and an N(β)—N(γ) distance of 1.128 (2) Å. The second, C(8)H(11)N(9)O(2)S, contains two azide groups with an average N(α)—N(β) distance of 1.249 (2) Å and an average N(β)—N(γ) distance of 1.132 (2) Å. Each compound contains a bulky protecting group (di­methyl­amino­sulfon­yl) which can be easily removed under mildly acidic conditions. International Union of Crystallography 2019-04-25 /pmc/articles/PMC6505610/ /pubmed/31110813 http://dx.doi.org/10.1107/S205698901900519X Text en © Cruz et al. 2019 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/
spellingShingle Research Communications
Cruz, Lorenzo M.
Moore, Raakiyah Y.
Gutierrez, Marcela Torres
Herath, Apsara K.
Lovely, Carl J.
Yousufuddin, Muhammed
Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide
title Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide
title_full Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide
title_fullStr Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide
title_full_unstemmed Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide
title_short Crystal structures of 4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(E)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-N,N-di­methyl­imidazole-1-sulfonamide
title_sort crystal structures of 4-{(e)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-n,n-di­methyl­imidazole-1-sulfonamide and 2-[(imino-λ(5)-aza­nyl­idene)amino]-4-{(e)-3-[(imino-λ(5)-aza­nyl­idene)amino]­prop-1-en­yl}-n,n-di­methyl­imidazole-1-sulfonamide
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505610/
https://www.ncbi.nlm.nih.gov/pubmed/31110813
http://dx.doi.org/10.1107/S205698901900519X
work_keys_str_mv AT cruzlorenzom crystalstructuresof4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamideand2iminol5azanylideneamino4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamide
AT mooreraakiyahy crystalstructuresof4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamideand2iminol5azanylideneamino4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamide
AT gutierrezmarcelatorres crystalstructuresof4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamideand2iminol5azanylideneamino4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamide
AT herathapsarak crystalstructuresof4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamideand2iminol5azanylideneamino4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamide
AT lovelycarlj crystalstructuresof4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamideand2iminol5azanylideneamino4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamide
AT yousufuddinmuhammed crystalstructuresof4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamideand2iminol5azanylideneamino4e3iminol5azanylideneaminoprop1enylnndimethylimidazole1sulfonamide